Home / Brands / Central Admixture Pharmacy Services
Central Admixture Pharmacy Services Recalls
347 recalls on record · September 3, 2014 to August 12, 2026 · Drugs
Recalls by year
14
15
23
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
August 12, 2026DrugsFDA
Central Admixture Pharmacy Services Inc recalls Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Compound Volume 416.8 mL per bag,
Hazard: Incorrect Product Formulation
July 1, 2026DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Rx# 24-1269856-0-1Compound Volume
Hazard: Incorrect product formulation: bag did not contain copper and famotidine per label.
March 19, 2025DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only, CAPS, Central Admixture Pharmacy Servi
Hazard: Presence of Particulate Matter
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in dextrose 5%, 0.5 mg/5 mL, (0.1 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc.
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% Sodium Chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Servic
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc.
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Serv
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Serv
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, C
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 1,250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc.,
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 5,000 mcg/100 mL, (50 mcg/mL), 100 mL Bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook R
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 100 mL bag, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dun
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San Di
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL, 100 mcg/2 mL, (50 mcg/mL), 3 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San Di
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 793
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 250 mL, Total fentaNYL 500 mcg/250
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50 mL, Total fentaNYL 75 mcg/50 m
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 5,000 mcg/250 mL, (20 mcg/mL), 250 mL Bag, Rx only, Central Admixture Pharmacy Service
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 2,500 mcg/250 mL, (10 mcg/mL), 250 mL bag, Rx only, Central Admixture Pharmacy Service
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 1,000 mcg/100 mL, (10 mcg/mL), 100 mL bag, Rx only, CAPS, Central Admixture Pharmacy S
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Service
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 100 mcg/10 mL, (10 mcg/mL), 10 mL Syringe, Rx only, Central Admixture Pharmacy Service
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx only, Central Admixture Pharmacy Services,
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls rocuronium, 50 mg/5 mL, (10 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls PHENYLephrine in 0.9% sodium chloride, 1,000 mcg/10 mL, (100 mcg/mL), 10 mL syringe, Rx only, Central Admixture Pharmacy
Hazard: Lack of assurance of sterility:
October 11, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls PHENYLephrine in 0.9 sodium chloride, 800 mcg/10 mL, (80 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road
Hazard: Lack of assurance of sterility: